PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 84 results · Immunology & Rheumatology  · Clear
🔒 Subscribers only
AUTH/2876/9/16
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
AbbVie
A health professional complained about a two-page Humira (adalimumab) journal advertisement (ref AXHUG160440b(2)) published in Gastrointestinal Nursing, September 2016.The ad included the claim: �…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2868/8/16
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Sanofi Genzyme
Janssen complained that at the EULAR Congress of Rheumatology (London, June 2016) Sanofi Genzyme promoted its forthcoming IL-6 receptor blocker, sarilumab, before it had a marketing authorization.T…
Clauses: 9.1
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2801/11/15
Off-label Promotion Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag voluntarily admitted that a two-page bound insert advertisement for Stelara (ustekinumab) in the Annals of Rheumatic Disease (ARD) October 2015 issue contained outdated prescribing in…
Clauses: 4.9,9.1
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2795/9/15
HCP Hospitality & Meetings Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Napp Pharmaceuticals
An anonymous, non-contactable ‘NHS whistleblower’ complained about Napp’s promotion of Remsima (infliximab), a biosimilar of Remicade, focusing on: (1) a UK HCP meeting held in Norway and (2)…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2762/5/15
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Astellas
A complaint was brought by the Director under Paragraph 5.1 against Astellas.The subject matter related to clinical trial disclosure for Betmiga.The PMCPA concluded the matter was outwith the scope…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2724/7/14
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Tillotts v Ferring
Tillotts complained about a cost comparison bar chart for Pentasa (mesalazine) in a Ferring e-detail aid (ref PA/283/2014/UK) titled: “Pentasa is less expensive than many other brands of 5-ASA”…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2714/5/14
HCP Hospitality & Meetings Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Pfizer
A consultant rheumatologist agreed to a short (“ten minute catch up”) meeting with a Pfizer representative; the representative arrived with a line manager, which the complainant said was not pr…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2706/3/14
Patient Organisations Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Tillotts detail aid on Octasa vs Asacol dissolution
Warner Chilcott UK (marketer of Asacol) complained about a Tillotts Pharma UK detail aid for Octasa (mesalazine MR), ref UK/OC/0002/0114.The complaint alleged the detail aid breached an undertaking…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2691/1/14
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Otsuka
A member of the public made a complaint to the PMCPA about clinical trial disclosure relating to Cimiza.The PMCPA determined the matter was outwith the scope of the ABPI Code of Practice.
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2592/4/13
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
GSK
GlaxoSmithKline (GSK) voluntarily admitted that two promotional patient case studies for Benlysta (belimumab) were emailed to health professionals as electronic “Dear Doctor” letters before cer…
Clauses: 9.1,9.2
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2587/3/13
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Almirall
An anonymous, non-contactable gastroenterology consultant alleged an Almirall representative told a colleague that free stock of Constella (linaclotide) could be offered as a trial to support a for…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2575/2/13
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Gedeon Richter
An ex-employee complained about “save the date” invitations for an Esmya (ulipristal acetate) meeting in Barcelona (April 2013), which were accessible via an events company website.The invitati…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2610/6/13
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Tillotts Pharma
Warner Chilcott UK complained about Tillotts Pharma UK’s promotion of Octasa (mesalazine modified-release tablets) via a journal supplement (ref UK/OC/0001/0113) published in the British Journal …
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2674/11/13
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, contactable member of the public complained about a published transparency study: “Clinical Trial Transparency: an assessment of the disclosure results of company-sponsored trials a…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2577/2/13
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
AbbVie
AbbVie voluntarily admitted that out-of-date prescribing information (PI) was linked to an online Humira (adalimumab) banner ad (ref AXHUR111644a) and included in a hard copy journal ad (ref AXHUR1…
Clauses: 4.1
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2658/11/13
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Member of the public v UCB (Cimzia)
A member of the public made a complaint about clinical trial disclosure relating to Cimzia.The PMCPA assessed the complaint under the ABPI Code of Practice (Applicable Code year: 2012).The case was…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2599/4/13
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Anonymous v Merck Sharp & Dohme
An anonymous, non-contactable complainant alleged Merck Sharp & Dohme (MSD) offered clinics/hospitals a retrospective rebate on Cerazette use over a 12‑month period to counter loss of share a…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2534/10/12
HCP Hospitality & Meetings Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Roche
An anonymous, non-contactable complainant alleged Roche pressured a named hospital employee (a pharmacist) to continue a rheumatoid arthritis (RA) remission data analysis project after a hospital g…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2408/6/11
HCP Hospitality & Meetings Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Abbott Laboratories
A consultant rheumatologist complained about delegates receiving an official EULAR 2011 conference bag in London (25–28 May 2011) branded with “Abbott” and the tagline “A Promise for Life�…
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2397/4/11
Data & Publications Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Hospital consultant v Warner Chilcott
A hospital consultant physician/gastroenterologist complained about a six-page gate-fold leavepiece for Asacol (modified release mesalazine) used with gastroenterologists and related health profess…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2423/7/11
Data & Publications Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Vifor Pharma
Pharmacosmos complained about a six-page gatefold leavepiece for Ferinject (ref 0090A/FER/2011) titled “Benefits of Ferinject in managing iron deficiency anaemia in inflammatory bowel disease (IB…
Clauses: 9.1,26.1
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2293/1/10
HCP Hospitality & Meetings Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Ferring
Ferring voluntarily admitted an abbreviated advertisement for Pentasa (mesalazine) in the Gastro 2009 conference programme (London, 21–25 Nov 2009) breached the Code.The ad was placed by global m…
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2299/2/10
HCP Hospitality & Meetings Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Ferring
Shire complained about Ferring’s promotion of Pentasa (mesalazine) using three items used at the Gastro 2009 Congress in London: a “power of five” booklet (ref PEN/011/11/09v2), an A4 sheet, …
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2238/6/09
Data & Publications Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Shire misleadingly presented Mezavant XL “68% maintained remission” claim (AUTH/2238/6/09)
Procter & Gamble complained that Shire’s promotional leavepieces for Mezavant XL (mesalazine prolonged release) presented maintenance-of-remission data in a misleading way.Two leavepieces (UK…
Clauses: 9.1
2009 🔒 Subscribe
← Prev 1 2 3 4 Next → Page 3 of 4 — 84 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews